Healthcare provider profile · identity verified

Darla Sue Murphy, MD

Family Practice · BURTON, MI · NPI 1841284437

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	608	169
Amlodipine Besylate	Amlodipine Besylate	344	99
Levothyroxine Sodium	Levothyroxine Sodium	309	89
Lisinopril	Lisinopril	285	77
Losartan Potassium	Losartan Potassium	256	74
Omeprazole	Omeprazole	229	73
Hydrochlorothiazide	Hydrochlorothiazide	167	46
Metformin Hcl	Metformin Hcl	157	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	153	47
Metoprolol Tartrate	Metoprolol Tartrate	150	39
Rosuvastatin Calcium	Rosuvastatin Calcium	143	52
Metoprolol Succinate	Metoprolol Succinate	140	46
Eliquis	Apixaban	127	30
Albuterol Sulfate Hfa	Albuterol Sulfate	125	48
Gabapentin	Gabapentin	124	36
Duloxetine Hcl	Duloxetine Hcl	118	38
Potassium Chloride	Potassium Chloride	115	38
Simvastatin	Simvastatin	105	33
Furosemide	Furosemide	104	35
Clopidogrel	Clopidogrel Bisulfate	103	31
Carvedilol	Carvedilol	97	30
Metformin Hcl Er	Metformin Hcl	77	26
Trazodone Hcl	Trazodone Hcl	77	25
Januvia	Sitagliptin Phosphate	76	15
Tamsulosin Hcl	Tamsulosin Hcl	75	25
Trulicity	Dulaglutide	67	14
Fluticasone Propionate	Fluticasone Propionate	64	28
Famotidine	Famotidine	63	24
Pravastatin Sodium	Pravastatin Sodium	63	19
Buspirone Hcl	Buspirone Hcl	62	22
Tramadol Hcl	Tramadol Hcl	62	20
Ezetimibe	Ezetimibe	61	18
Escitalopram Oxalate	Escitalopram Oxalate	59	24
Meloxicam	Meloxicam	57	15
Prednisone	Prednisone	56	46
Allopurinol	Allopurinol	54	16
Pantoprazole Sodium	Pantoprazole Sodium	54	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	47
Sertraline Hcl	Sertraline Hcl	50	15
Tizanidine Hcl	Tizanidine Hcl	49	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	16
Montelukast Sodium	Montelukast Sodium	47	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	14
Bumetanide	Bumetanide	46	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	15
Enalapril Maleate	Enalapril Maleate	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	11
Spironolactone	Spironolactone	41	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	15
Ventolin Hfa	Albuterol Sulfate	37	14
Citalopram Hbr	Citalopram Hydrobromide	35	11
Pregabalin	Pregabalin	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	29
Acetaminophen-Codeine	Acetaminophen With Codeine	31	suppressed
Bupropion Xl	Bupropion Hcl	31	13
Hydralazine Hcl	Hydralazine Hcl	31	11
Nifedipine Er	Nifedipine	31	12
Ozempic	Semaglutide	30	13
Jardiance	Empagliflozin	29	12
Lovastatin	Lovastatin	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Xarelto	Rivaroxaban	29	suppressed
Topiramate	Topiramate	28	11
Clonazepam	Clonazepam	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Levetiracetam	Levetiracetam	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	25	13
Ibuprofen	Ibuprofen	25	15
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Mirtazapine	Mirtazapine	24	11
Atenolol	Atenolol	23	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Fluconazole	Fluconazole	22	20
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Azithromycin	Azithromycin	21	19
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Glipizide	Glipizide	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Baclofen	Baclofen	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Irbesartan	Irbesartan	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Ramipril	Ramipril	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Valsartan	Valsartan	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Clonidine	Clonidine	13	suppressed
Levofloxacin	Levofloxacin	13	11
Lubiprostone	Lubiprostone	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error